Humana Inc.
NYSE:HUMMedical - Healthcare Plans
Healthcare
$389.91 +0.19%
+$0.70 today
- Market cap
- $46.83B
- Beta
- 0.77
- P/E (TTM)
- 38.6
- EPS (TTM)
- $9.39
- Dividend yield
- 0.98%
52W Low $163.11High $380.86
Volume 2.10M
Average 1.72M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$921.00M
FY 2025 · Annual
-68.9% YoYInvesting Cash Flow
$2.27B
FY 2025 · Annual
Financing Cash Flow
-$1.22B
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.93B | 2.8B | 2.49B | 1.21B | 1.2B |
| Depreciation & Amortization | 713M | 845M | 917M | 968M | 824M |
| Deferred Income Tax | 15M | (100M) | (167M) | (192M) | 75M |
| Stock-Based Compensation | 180M | 216M | 175M | 207M | 241M |
| Change in Working Capital | (556M) | 534M | 81M | 154M | (1.8B) |
| Accounts Receivables | (280M) | (54M) | (337M) | (669M) | (570M) |
| Inventory | 0 | 0 | (364M) | 0 | 0 |
| Accounts Payables | 104M | 975M | 915M | 199M | (472M) |
| Other Working Capital | (380M) | (387M) | (133M) | 624M | (755M) |
| Other Non-Cash Items | (1.02B) | 290M | 486M | 615M | 375M |
| Operating Cash Flow | 2.26B | 4.59B | 3.98B | 2.97B | 921M |
| Capital Expenditures | (1.34B) | (1.14B) | (1B) | (575M) | (546M) |
| Acquisitions (Net) | (4.19B) | 2.36B | (233M) | (89M) | (81M) |
| Purchases of Investments | (7.2B) | (6.05B) | (7.55B) | (8.19B) | (6.44B) |
| Sales of Investments | 6.14B | 3.8B | 5.09B | 6.36B | 9.42B |
| Other Investing Activities | 26M | 17M | 210M | (461M) | (82M) |
| Investing Cash Flow | (6.56B) | (1.01B) | (3.49B) | (2.95B) | 2.27B |
| Debt Repayment | 3.76B | (1.39B) | 423M | 218M | 431M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (79M) | (2.1B) | (1.57B) | (817M) | (151M) |
| Dividends Paid | (354M) | (392M) | (431M) | (431M) | (430M) |
| Other Financing Activities | (310M) | 1.97B | 725M | (1.46B) | (1.07B) |
| Financing Cash Flow | 3.02B | (1.91B) | (856M) | (2.49B) | (1.22B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.28B) | 1.67B | (367M) | (2.47B) | 1.98B |
| Free Cash Flow | 920M | 3.45B | 2.98B | 2.39B | 375M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$1.2B
+ D&A$824.0M
+ Stock-Based Comp$241.0M
+ Deferred Tax$75.0M
- Working Capital-$1.8B
+ Other Non-Cash$375.0M
= Operating Cash Flow$921.0M
- Capex-$546.0M
= Free Cash Flow$375.0M
Analysis
FY2025 free cash flow is $375.0M. FCF conversion is 31.2% of net income. Operating cash flow was $921.0M, with capex of -$546.0M. The largest bridge item is Working Capital at -$1.8B.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 6, 2026 |
Does HUM generate free cash flow?
Humana Inc. (HUM) generated $375.00M of free cash flow in fiscal 2025.
How much operating cash flow does HUM produce?
Operating cash flow was $921.00M, before capital expenditures of $546.00M.
Continue the stock analysis
Jump to another research area for this company.